Heart failure is a common disease state that can be encountered at different stages in the
course of a COVID-19 patient presentation. New or existing heart failure in the setting of …

Coronavirus disease 2019 (COVID-19) has emerged as a pandemic with serious clinical
manifestations including death. A pandemic at the large-scale like COVID-19 places …

2021 Update to the 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart
Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection …

Background Patients with pre-existing heart failure (HF) are likely at higher risk for adverse
outcomes in coronavirus disease-2019 (COVID-19), but data on this population are sparse …

Background The COVID-19 pandemic has driven primary healthcare (PHC) providers to use
telehealth as an alternative to traditional face-to-face consultations. Providing telehealth that …

Among the estimated 6.2 million Americans living with heart failure (HF),≈ 5%/y may
progress to advanced, or stage D, disease. Advanced HF has a high morbidity and mortality …

Aims Heart failure (HF) leads to repeat hospitalisations and reduces the duration and quality
of life. Pulmonary artery pressure (PAP)‐guided HF management using the CardioMEMS™ …

Lay Summary The cost of heart failure care is high owing to the cost of hospitalization and
chronic treatments. Heart failure treatments vary in their benefit and cost. The cost …

The novel coronavirus disease 2019, otherwise known as COVID-19, is a global pandemic
with primary respiratory manifestations in those who are symptomatic. It has spread to> 187 …

Background The coronavirus disease 2019 (COVID-19) pandemic brought about abrupt
changes in the way health care is delivered, and the impact of transitioning outpatient clinic …